Atrial Fibrillation

Atrial Fibrillation Management The central role of the GP

Atrial Fibrillation Management The central role of the GP

Opportunistic screening for atrial fibrillation (AF) is recommended for all patients aged over 65 years, and choosing between a rate and rhythm control strategy is important. Beta-blockers or nondihydropyridine calcium
channel antagonists are the first choice for rate control.
Flecainide is preferable for the pharmacologic rhythm control. The sexless CHA2DS2-VA assessment is recommended to assess stroke risk. Integrated care to support comprehensive treatment and address the specific needs of people with AF is required, and GPs are central to its effective delivery.

Modern Medicine – Issue 4 2020

August 14, 2020 by Anticoagulants Atrial Fibrillation Cardiology

Atrial Fibrillation: A New Perspective on an Old Problem

Atrial Fibrillation: A New Perspective on an Old Problem – MM1701

The three cornerstones of atrial fibrillation (AF) management have traditionally been anticoagulation, rate control and rhythm control. There is evidence that modification of the following main risk factors, obstructive sleep apnoea, obesity and exercise improves outcomes. Treatment of patients with sleep apnoea using continuous positive airway pressure reduces the risk and recurrence of AF. Patients undergoing cardioversion or AF ablation should be actively screened for sleep apnoea and treated if it is present. Light to moderate exercise is protective against AF. Risk factor management is essential in conjunction with antiarrhythmic medications and AF ablation to maximise treatment effects.

Modern Medicine – January 2017

January 27, 2017 by Atrial Fibrillation Cardiology
Verified by ExactMetrics